Quick Answer
Harmony Biosciences Holdings, Inc. reported Shares Outstanding of 57.73 million shares for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 57.73M | +1.0% |
| 2024 | 57.14M | +0.7% |
| 2023 | 56.77M | -4.8% |
| 2022 | 59.62M | +1.3% |
| 2021 | 58.83M | +3.4% |
| 2020 | 56.89M | +630.5% |
| 2019 | 7.79M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 57.60M | +1.0% | +0.1% |
| June 30, 2025 | 57.54M | +1.2% | +0.3% |
| March 31, 2025 | 57.39M | +1.1% | +0.4% |
| December 31, 2024 | 57.14M | +0.7% | +0.2% |
| September 30, 2024 | 57.03M | -2.6% | +0.3% |
| June 30, 2024 | 56.83M | -5.3% | +0.1% |
| March 31, 2024 | 56.79M | -5.3% | +0.0% |
| December 31, 2023 | 56.77M | -4.8% | -3.1% |
- Harmony Biosciences Holdings, Inc. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Harmony Biosciences Holdings, Inc.’s shares outstanding has grown by 641.3% (from 7.79 million shares to 57.73 million shares).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: